Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum
Public ClinicalTrials.gov record NCT01355497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer on First Line Platinum Plus a Non-Taxane Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if the investigational drug GTx-024 can help patients with non small cell lung cancer increase physical function and maintain or gain muscle.
Study identification
- NCT ID
- NCT01355497
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2011 (Type not available)
- Primary completion
- May 2013 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Nov 9, 2020
2011 – 2014
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GTx Investigative Site | Birmingham | Alabama | 35211 | — |
| GTx Investigative Site | Scottsdale | Arizona | 85255 | — |
| GTx Investigative Site | La Jolla | California | 92093 | — |
| GTx Investigative Site | Long Beach | California | 90813 | — |
| GTx Investigative Site | Miami | Florida | 33133 | — |
| GTx Investigative Site | Orange City | Florida | 32763 | — |
| GTx Investigative Site | Tampa | Florida | 33612 | — |
| GTx Investigative Site | Decatur | Illinois | 62526 | — |
| GTx Investigative Site | Peoria | Illinois | 61615 | — |
| GTx Investigative Site | Skokie | Illinois | 60076 | — |
| GTx Investigative Site | Goshen | Indiana | 46526 | — |
| GTx Investigative Site | Indianapolis | Indiana | 46260 | — |
| GTx Investigative Site | Ashland | Kentucky | 41101 | — |
| GTx Investigative Site | Concord | Massachusetts | 01742 | — |
| GTx Investigative Site | Saint Clair Shores | Michigan | 48081 | — |
| GTx Investigative Site | Tupelo | Mississippi | 38801 | — |
| GTx Investigative Site | Great Falls | Montana | 59405 | — |
| GTx Investigative Site | Rochester | New York | 14642 | — |
| GTx Investigative Site | Burlington | North Carolina | 27215 | — |
| GTx Investigator | Flat Rock | North Carolina | 28731 | — |
| GTx Investigative Site | Wilmington | North Carolina | 28401 | — |
| GTx Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| GTx Investigative Site | Canfield | Ohio | 44406 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| GTx Investigative Site | Sandusky | Ohio | 44870 | — |
| GTx Investigative Site | Portland | Oregon | 97213 | — |
| GTx Investigative Site | Lancaster | Pennsylvania | 17604 | — |
| GTx Investigative Site | Spartanburg | South Carolina | 29303 | — |
| GTx Investigative Site | Nashville | Tennessee | 37203 | — |
| GTx Investigative Site | Round Rock | Texas | 78665 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01355497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 9, 2020 · Synced Nov 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01355497 live on ClinicalTrials.gov.